GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » Inventories, Finished Goods

Shire (SHPG) Inventories, Finished Goods : $960 Mil (As of Sep. 2018)


View and export this data going back to 1998. Start your Free Trial

What is Shire Inventories, Finished Goods?

Shire's quarterly finished goods increased from Mar. 2018 ($0 Mil) to Jun. 2018 ($951 Mil) and increased from Jun. 2018 ($951 Mil) to Sep. 2018 ($960 Mil).

Shire's annual finished goods increased from Dec. 2015 ($185 Mil) to Dec. 2016 ($1,380 Mil) but then declined from Dec. 2016 ($1,380 Mil) to Dec. 2017 ($926 Mil).

Shire Inventories, Finished Goods Historical Data

The historical data trend for Shire's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shire Inventories, Finished Goods Chart

Shire Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 156.60 136.00 184.90 1,380.00 926.10

Shire Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 909.00 926.10 - 951.00 959.70

Shire Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Shire (SHPG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » Inventories, Finished Goods
Comparable Companies
VRTX REGN ASX:CSL ALXN XKRX:207940 SGEN INCY XKRX:068270 HKSE:01177 XBRU:UCB OCSE:GMAB HKSE:02269 BMRN HKSE:06160 XAMS:GLPG ALNY ARRY NBIX SZSE:300122 IONS
Traded in Other Exchanges
N/A
Address
Website
http://www.shire.com
Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.
Executives
James H Cavanaugh director 265 HOTHORPE LANE, VILLANOVA PA 19085